Abeona Therapeutics
ABEO
56 hedge funds and large institutions have $105M invested in Abeona Therapeutics in 2024 Q1 according to their latest regulatory filings, with 15 funds opening new positions, 22 increasing their positions, 12 reducing their positions, and 7 closing their positions.
1,106% more call options, than puts
Call options by funds: $5.35M | Put options by funds: $444K
114% more first-time investments, than exits
New positions opened: 15 | Existing positions closed: 7
83% more repeat investments, than reductions
Existing positions increased: 22 | Existing positions reduced: 12
48% more capital invested
Capital invested by funds: $70.9M → $105M (+$33.8M)
17% more funds holding
Funds holding: 48 → 56 (+8)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
4.34% less ownership
Funds ownership: 57.15% → 52.81% (-4.3%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
LCM
Laurion Capital Management
New York
|
+$4.1M |
| 2 |
Millennium Management
New York
|
+$3.6M |
| 3 |
WSL
Western Standard LLC
Los Angeles,
California
|
+$3.51M |
| 4 |
IC
Ikarian Capital
Dallas,
Texas
|
+$1.83M |
| 5 |
Goldman Sachs
New York
|
+$1.09M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ACM
AIGH Capital Management
Baltimore,
Maryland
|
-$3.95M |
| 2 |
Point72 Asset Management
Stamford,
Connecticut
|
-$3.81M |
| 3 |
JGC
J. Goldman & Co
New York
|
-$2.58M |
| 4 |
DMKJ
David M. Knott Jr
|
-$993K |
| 5 |
WVP
Worth Venture Partners
Fort Lee,
New Jersey
|
-$984K |
ABEO Hedge Fund Activity: Q1 2024 in Review
56 of the 6,942 institutional investors tracked by Wall St. Rank reported a position in Abeona Therapeutics (ABEO) for Q1 2024, worth a combined $105M — up 48% from $70.9M a quarter earlier.
Buyers outnumbered sellers: 15 funds opened new ABEO positions and 7 closed out — a net gain of 8 holders — while 22 added to existing stakes and 12 trimmed.
The largest buyer was Laurion Capital Management, opening a new position worth an estimated $4.1M. The largest seller was AIGH Capital Management, exiting entirely with an estimated $3.95M sold.
- 56 institutional investors held Abeona Therapeutics (ABEO) as of Q1 2024, up from 48 in Q4 2023.
- Funds reported $105M of Abeona Therapeutics stock for Q1 2024, up 48% quarter-over-quarter.
- 15 funds opened new Abeona Therapeutics positions in Q1 2024 and 7 closed out, a net change of +8 holders.
- The largest Abeona Therapeutics buyer in Q1 2024 was Laurion Capital Management, an estimated $4.1M added.
- The largest Abeona Therapeutics seller in Q1 2024 was AIGH Capital Management, an estimated $3.95M sold.
Based on aggregated 13F filings for Q1 2024.